Back

A

Absolute Risk Reduction (ARR)

B

Base Case Analysis

Bayesian Analysis

Budget Impact Analysis (BIA) / Budget Impact Model (BIM)

C

Cost Minimisation Analysis (CMA)

Cost of Illness (COI)

Cost-Benefit Analysis (CBA)

Cost-Effectiveness Analysis (CEA)

Cost-Effectiveness Threshold

Cost-Utility Analysis (CUA)

Critical Appraisal

D

Decision Tree

Deterministic Sensitivity Analysis

Disability-Adjusted Life-Years (DALYs)

Discount Rate

Discrete Choice Experiment (DCE)

Discrete Event Simulation (DES)

Disutility

E

Early Health Economics Modelling / Early Health Economic Assessment

Economic Modelling

EuroQol EQ-5D

Evidence-Based Procurement (EBP)

Expected Value of Partially Perfect Information (EVPPI)

Expected Value of Perfect Information (EVPI)

Expected Value of Sample Information (EVSI)

H

Half-Cycle Correction

Health Economics

Health Economics and Outcomes Research (HEOR)

Health Economic Evaluation

Health Technology Assessment (HTA)

Highly Specialised Technologies (HST)

I

Incremental Cost-Effectiveness Ratio (ICER)

Indirect Treatment Comparison (ITC)

Intention to Treat (ITT) Analysis

L

Literature Review

M

Managed Access Agreement (MAA)

Market Access

Markov Model

Matching-Adjusted Indirect Comparison (MAIC) 

Meta-Analysis

Micro-Simulation

Minimally Clinically Important Differences (MCID)

Mixed Treatment Comparison (MTC)

Monte-Carlo Simulation

Multi-way Sensitivity Analysis

Multiple Technology Appraisal (MTA)

N

Negative Predictive Value (NPV)

Net Health Benefit (NHB)

Net Monetary Benefit (NMB)

Network Meta-Analysis (NMA)

Non-Inferiority (Study)

Number Needed to Treat (NNT)

O

Outcomes Research

P

Partitioned Survival Model

Patient Access Scheme (PAS)

Patient-Level Simulation Model

Patient-Reported Outcome Measures (PROMs)

Patient-Reported Outcomes (PROs)

Perspective

Positive Predictive Value (PPV)

Precision Medicine / Personalized Medicine

Preference-Based Measures (PBMs)

Probabilistic Sensitivity Analysis

Q

Quality of Life

Quality-Adjusted Life Year (QALY)

R

Reference Case

Risk of Bias

S

Search Strategy

Sensitivity

Sensitivity Analysis

Single Technology Appraisal (STA)

Specificity

Standard Gamble (SG)

Structured Literature Review/Targeted Literature Review

Survival Analysis

Systematic Review

T

Time Horizon

Time Trade-Off (TTO)

Tornado Diagram

Two Way Sensitivity Analysis

U

Unit Costs

Univariate/One Way Sensitivity Analysis

Uptake

Utility

V

Value Based Pricing

Value of Information Analysis

Value-Based Healthcare

W

Willingness-to-Pay (WTP)